Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil
Identifieur interne : 002A89 ( Pmc/Corpus ); précédent : 002A88; suivant : 002A90Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil
Auteurs : Daniella Mf Paiva ; Vivian O. Rodrigues ; Marcelle G. Cesca ; Pamella V. Palma ; Isabel Cg LeiteSource :
- BMC Women's Health [ 1472-6874 ] ; 2013.
Abstract
Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.
We performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded. Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment.
The prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in 5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).
The prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the morbidity of this disease.
Url:
DOI: 10.1186/1472-6874-13-6
PubMed: 23406386
PubMed Central: 3577444
Links to Exploration step
PMC:3577444Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil</title><author><name sortKey="Paiva, Daniella Mf" sort="Paiva, Daniella Mf" uniqKey="Paiva D" first="Daniella Mf" last="Paiva">Daniella Mf Paiva</name><affiliation><nlm:aff id="I1">School of Medical Sciences and Health, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Rodrigues, Vivian O" sort="Rodrigues, Vivian O" uniqKey="Rodrigues V" first="Vivian O" last="Rodrigues">Vivian O. Rodrigues</name><affiliation><nlm:aff id="I2">School of Medicine, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Cesca, Marcelle G" sort="Cesca, Marcelle G" uniqKey="Cesca M" first="Marcelle G" last="Cesca">Marcelle G. Cesca</name><affiliation><nlm:aff id="I2">School of Medicine, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Palma, Pamella V" sort="Palma, Pamella V" uniqKey="Palma P" first="Pamella V" last="Palma">Pamella V. Palma</name><affiliation><nlm:aff id="I3">School of Dentistry, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Leite, Isabel Cg" sort="Leite, Isabel Cg" uniqKey="Leite I" first="Isabel Cg" last="Leite">Isabel Cg Leite</name><affiliation><nlm:aff id="I4">Public Health Department of the School of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23406386</idno><idno type="pmc">3577444</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577444</idno><idno type="RBID">PMC:3577444</idno><idno type="doi">10.1186/1472-6874-13-6</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">002A89</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002A89</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil</title><author><name sortKey="Paiva, Daniella Mf" sort="Paiva, Daniella Mf" uniqKey="Paiva D" first="Daniella Mf" last="Paiva">Daniella Mf Paiva</name><affiliation><nlm:aff id="I1">School of Medical Sciences and Health, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Rodrigues, Vivian O" sort="Rodrigues, Vivian O" uniqKey="Rodrigues V" first="Vivian O" last="Rodrigues">Vivian O. Rodrigues</name><affiliation><nlm:aff id="I2">School of Medicine, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Cesca, Marcelle G" sort="Cesca, Marcelle G" uniqKey="Cesca M" first="Marcelle G" last="Cesca">Marcelle G. Cesca</name><affiliation><nlm:aff id="I2">School of Medicine, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Palma, Pamella V" sort="Palma, Pamella V" uniqKey="Palma P" first="Pamella V" last="Palma">Pamella V. Palma</name><affiliation><nlm:aff id="I3">School of Dentistry, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author><author><name sortKey="Leite, Isabel Cg" sort="Leite, Isabel Cg" uniqKey="Leite I" first="Isabel Cg" last="Leite">Isabel Cg Leite</name><affiliation><nlm:aff id="I4">Public Health Department of the School of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil</nlm:aff></affiliation></author></analytic><series><title level="j">BMC Women's Health</title><idno type="eISSN">1472-6874</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.</p></sec><sec><title>Methods</title><p>We performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded. Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment.</p></sec><sec><title>Results</title><p>The prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in 5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).</p></sec><sec><title>Conclusions</title><p>The prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the morbidity of this disease.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Guerra, Mr" uniqKey="Guerra M">MR Guerra</name></author><author><name sortKey="Mendonca, Gas" uniqKey="Mendonca G">GAS Mendonça</name></author><author><name sortKey="Bustamante Teixeira, Mt" uniqKey="Bustamante Teixeira M">MT Bustamante-Teixeira</name></author><author><name sortKey="Cintra, Jrd" uniqKey="Cintra J">JRD Cintra</name></author><author><name sortKey="Carvalho, Lm" uniqKey="Carvalho L">LM Carvalho</name></author><author><name sortKey="Magalhaes, Lmpv" uniqKey="Magalhaes L">LMPV Magalhães</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Beaulac, Sm" uniqKey="Beaulac S">SM Beaulac</name></author><author><name sortKey="Mcnair, La" uniqKey="Mcnair L">LA McNair</name></author><author><name sortKey="Scott, Te" uniqKey="Scott T">TE Scott</name></author><author><name sortKey="Lamorte, Ww" uniqKey="Lamorte W">WW LaMorte</name></author><author><name sortKey="Kavanah, Mt" uniqKey="Kavanah M">MT Kavanah</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dayes, Is" uniqKey="Dayes I">IS Dayes</name></author><author><name sortKey="Levine, Mn" uniqKey="Levine M">MN Levine</name></author><author><name sortKey="Julian, Ja" uniqKey="Julian J">JA Julian</name></author><author><name sortKey="Pritchard, Ki" uniqKey="Pritchard K">KI Pritchard</name></author><author><name sortKey="D Ouza, Dp" uniqKey="D Ouza D">DP D’Souza</name></author><author><name sortKey="Kligman, L" uniqKey="Kligman L">L Kligman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sampaio, Ebm" uniqKey="Sampaio E">EBM Sampaio</name></author><author><name sortKey="Albuquerque, Iman" uniqKey="Albuquerque I">IMAN Albuquerque</name></author><author><name sortKey="Linhares, Jj" uniqKey="Linhares J">JJ Linhares</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Engel, J" uniqKey="Engel J">J Engel</name></author><author><name sortKey="Kerr, J" uniqKey="Kerr J">J Kerr</name></author><author><name sortKey="Schlesinger Raab, A" uniqKey="Schlesinger Raab A">A Schlesinger-Raab</name></author><author><name sortKey="Sauer, H" uniqKey="Sauer H">H Sauer</name></author><author><name sortKey="Holzel, D" uniqKey="Holzel D">D Hölzel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bergmann, A" uniqKey="Bergmann A">A Bergmann</name></author><author><name sortKey="Mattos, Ie" uniqKey="Mattos I">IE Mattos</name></author><author><name sortKey="Koiffman, Rj" uniqKey="Koiffman R">RJ Koiffman</name></author><author><name sortKey="Ribeiro, Mjp" uniqKey="Ribeiro M">MJP Ribeiro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Buchholz, T" uniqKey="Buchholz T">T Buchholz</name></author><author><name sortKey="Avristscher, R" uniqKey="Avristscher R">R Avristscher</name></author><author><name sortKey="Yu, Tk" uniqKey="Yu T">TK Yu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stanton, Aw" uniqKey="Stanton A">AW Stanton</name></author><author><name sortKey="Modi, S" uniqKey="Modi S">S Modi</name></author><author><name sortKey="Mellor, Rh" uniqKey="Mellor R">RH Mellor</name></author><author><name sortKey="Levick, Jr" uniqKey="Levick J">JR Levick</name></author><author><name sortKey="Mortimer, Ps" uniqKey="Mortimer P">PS Mortimer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Armer, Jm" uniqKey="Armer J">JM Armer</name></author><author><name sortKey="Stewart, Br" uniqKey="Stewart B">BR Stewart</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gartner, R" uniqKey="Gartner R">R Gartner</name></author><author><name sortKey="Jesse, Mb" uniqKey="Jesse M">MB Jesse</name></author><author><name sortKey="Kronborg, L" uniqKey="Kronborg L">L Kronborg</name></author><author><name sortKey="Ewertz, M" uniqKey="Ewertz M">M Ewertz</name></author><author><name sortKey="Kehlet, H" uniqKey="Kehlet H">H Kehlet</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Deo, Sv" uniqKey="Deo S">SV Deo</name></author><author><name sortKey="Ray, S" uniqKey="Ray S">S Ray</name></author><author><name sortKey="Rath, Gk" uniqKey="Rath G">GK Rath</name></author><author><name sortKey="Shukla, Nk" uniqKey="Shukla N">NK Shukla</name></author><author><name sortKey="Kar, M" uniqKey="Kar M">M Kar</name></author><author><name sortKey="Asthana, S" uniqKey="Asthana S">S Asthana</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Soran, A" uniqKey="Soran A">A Soran</name></author><author><name sortKey="Wu, Wc" uniqKey="Wu W">WC Wu</name></author><author><name sortKey="Dirican, A" uniqKey="Dirican A">A Dirican</name></author><author><name sortKey="Johnson, R" uniqKey="Johnson R">R Johnson</name></author><author><name sortKey="Andacoglu, O" uniqKey="Andacoglu O">O Andacoglu</name></author><author><name sortKey="Wilson, J" uniqKey="Wilson J">J Wilson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Norman, Sa" uniqKey="Norman S">SA Norman</name></author><author><name sortKey="Localio, Ar" uniqKey="Localio A">AR Localio</name></author><author><name sortKey="Potashnik, Sl" uniqKey="Potashnik S">SL Potashnik</name></author><author><name sortKey="Simoes Torpey, Ha" uniqKey="Simoes Torpey H">HA Simoes Torpey</name></author><author><name sortKey="Kallan, Mj" uniqKey="Kallan M">MJ Kallan</name></author><author><name sortKey="Weber, Al" uniqKey="Weber A">AL Weber</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kwan, Ml" uniqKey="Kwan M">ML Kwan</name></author><author><name sortKey="Darbinian, J" uniqKey="Darbinian J">J Darbinian</name></author><author><name sortKey="Schmitz, Kh" uniqKey="Schmitz K">KH Schmitz</name></author><author><name sortKey="Citron, R" uniqKey="Citron R">R Citron</name></author><author><name sortKey="Partee, P" uniqKey="Partee P">P Partee</name></author><author><name sortKey="Kutner, Se" uniqKey="Kutner S">SE Kutner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hayes, Sc" uniqKey="Hayes S">SC Hayes</name></author><author><name sortKey="Janda, M" uniqKey="Janda M">M Janda</name></author><author><name sortKey="Cornish, B" uniqKey="Cornish B">B Cornish</name></author><author><name sortKey="Battistutta, D" uniqKey="Battistutta D">D Battistutta</name></author><author><name sortKey="Newman, B" uniqKey="Newman B">B Newman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hunt, Kk" uniqKey="Hunt K">KK Hunt</name></author><author><name sortKey="Askew, R" uniqKey="Askew R">R Askew</name></author><author><name sortKey="Cormier, Jn" uniqKey="Cormier J">JN Cormier</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cormier, Jn" uniqKey="Cormier J">JN Cormier</name></author><author><name sortKey="Askew, Rl" uniqKey="Askew R">RL Askew</name></author><author><name sortKey="Mungovan, Ks" uniqKey="Mungovan K">KS Mungovan</name></author><author><name sortKey="Xing, Y" uniqKey="Xing Y">Y Xing</name></author><author><name sortKey="Ross, Mi" uniqKey="Ross M">MI Ross</name></author><author><name sortKey="Armer, Jm" uniqKey="Armer J">JM Armer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Thomas Maclean, Rl" uniqKey="Thomas Maclean R">RL Thomas-Maclean</name></author><author><name sortKey="Hack, T" uniqKey="Hack T">T Hack</name></author><author><name sortKey="Kwan, W" uniqKey="Kwan W">W Kwan</name></author><author><name sortKey="Towers, A" uniqKey="Towers A">A Towers</name></author><author><name sortKey="Miedema, B" uniqKey="Miedema B">B Miedema</name></author><author><name sortKey="Tilley, A" uniqKey="Tilley A">A Tilley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tsai, Rj" uniqKey="Tsai R">RJ Tsai</name></author><author><name sortKey="Dennis, Lk" uniqKey="Dennis L">LK Dennis</name></author><author><name sortKey="Lynch, Cf" uniqKey="Lynch C">CF Lynch</name></author><author><name sortKey="Snetselaar, Lg" uniqKey="Snetselaar L">LG Snetselaar</name></author><author><name sortKey="Zamba, Gk" uniqKey="Zamba G">GK Zamba</name></author><author><name sortKey="Scott Conner, C" uniqKey="Scott Conner C">C Scott-Conner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yen, Tw" uniqKey="Yen T">TW Yen</name></author><author><name sortKey="Fan, X" uniqKey="Fan X">X Fan</name></author><author><name sortKey="Sparapani, R" uniqKey="Sparapani R">R Sparapani</name></author><author><name sortKey="Laud, Pw" uniqKey="Laud P">PW Laud</name></author><author><name sortKey="Walker, Ap" uniqKey="Walker A">AP Walker</name></author><author><name sortKey="Nattinger, Ab" uniqKey="Nattinger A">AB Nattinger</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shih, Yc" uniqKey="Shih Y">YC Shih</name></author><author><name sortKey="Xu, Y" uniqKey="Xu Y">Y Xu</name></author><author><name sortKey="Cormier, Jn" uniqKey="Cormier J">JN Cormier</name></author><author><name sortKey="Giordano, S" uniqKey="Giordano S">S Giordano</name></author><author><name sortKey="Ridner, Sh" uniqKey="Ridner S">SH Ridner</name></author><author><name sortKey="Buchholz, Ta" uniqKey="Buchholz T">TA Buchholz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Harmer, V" uniqKey="Harmer V">V Harmer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Norman, Sa" uniqKey="Norman S">SA Norman</name></author><author><name sortKey="Localio, Ar" uniqKey="Localio A">AR Localio</name></author><author><name sortKey="Kallan, Mj" uniqKey="Kallan M">MJ Kallan</name></author><author><name sortKey="Weber, Al" uniqKey="Weber A">AL Weber</name></author><author><name sortKey="Torpey, Ha" uniqKey="Torpey H">HA Torpey</name></author><author><name sortKey="Potashnik, Sl" uniqKey="Potashnik S">SL Potashnik</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Clough Gorr, Km" uniqKey="Clough Gorr K">KM Clough-Gorr</name></author><author><name sortKey="Ganz, Pa" uniqKey="Ganz P">PA Ganz</name></author><author><name sortKey="Silliman, Ra" uniqKey="Silliman R">RA Silliman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Meeske, Ka" uniqKey="Meeske K">KA Meeske</name></author><author><name sortKey="Sullivan Halley, J" uniqKey="Sullivan Halley J">J Sullivan-Halley</name></author><author><name sortKey="Smith, Aw" uniqKey="Smith A">AW Smith</name></author><author><name sortKey="Mctiernan, A" uniqKey="Mctiernan A">A McTiernan</name></author><author><name sortKey="Baumgartner, Kb" uniqKey="Baumgartner K">KB Baumgartner</name></author><author><name sortKey="Harlan, Lc" uniqKey="Harlan L">LC Harlan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Goffman, Te" uniqKey="Goffman T">TE Goffman</name></author><author><name sortKey="Laronga, C" uniqKey="Laronga C">C Laronga</name></author><author><name sortKey="Wilson, L" uniqKey="Wilson L">L Wilson</name></author><author><name sortKey="Elkins, D" uniqKey="Elkins D">D Elkins</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mak, Ss" uniqKey="Mak S">SS Mak</name></author><author><name sortKey="Yeo, W" uniqKey="Yeo W">W Yeo</name></author><author><name sortKey="Lee, Ym" uniqKey="Lee Y">YM Lee</name></author><author><name sortKey="Tse, Sm" uniqKey="Tse S">SM Tse</name></author><author><name sortKey="Ho, Fp" uniqKey="Ho F">FP Ho</name></author><author><name sortKey="Zee, B" uniqKey="Zee B">B Zee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hojris, I" uniqKey="Hojris I">I Hojris</name></author><author><name sortKey="Andersen, J" uniqKey="Andersen J">J Andersen</name></author><author><name sortKey="Overgaard, M" uniqKey="Overgaard M">M Overgaard</name></author><author><name sortKey="Overgaard, J" uniqKey="Overgaard J">J Overgaard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bergmann, A" uniqKey="Bergmann A">A Bergmann</name></author><author><name sortKey="Mattos, Ie" uniqKey="Mattos I">IE Mattos</name></author><author><name sortKey="Koiffman, Rj" uniqKey="Koiffman R">RJ Koiffman</name></author><author><name sortKey="Ribeiro, Mjp" uniqKey="Ribeiro M">MJP Ribeiro</name></author><author><name sortKey="Nogueira, Ea" uniqKey="Nogueira E">EA Nogueira</name></author><author><name sortKey="Ribeiro, Ep" uniqKey="Ribeiro E">EP Ribeiro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Leidenius, M" uniqKey="Leidenius M">M Leidenius</name></author><author><name sortKey="Lepp Nen, E" uniqKey="Lepp Nen E">E Leppänen</name></author><author><name sortKey="Krogerus, L" uniqKey="Krogerus L">L Krogerus</name></author><author><name sortKey="Von Smitten, K" uniqKey="Von Smitten K">K von Smitten</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moskovitz, Ah" uniqKey="Moskovitz A">AH Moskovitz</name></author><author><name sortKey="Anderson, Bo" uniqKey="Anderson B">BO Anderson</name></author><author><name sortKey="Yeung, Rs" uniqKey="Yeung R">RS Yeung</name></author><author><name sortKey="Byrd, Dr" uniqKey="Byrd D">DR Byrd</name></author><author><name sortKey="Lawton, Tj" uniqKey="Lawton T">TJ Lawton</name></author><author><name sortKey="Moe, Re" uniqKey="Moe R">RE Moe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Johansen, J" uniqKey="Johansen J">J Johansen</name></author><author><name sortKey="Overgaard, J" uniqKey="Overgaard J">J Overgaard</name></author><author><name sortKey="Blichert Toft, M" uniqKey="Blichert Toft M">M Blichert-Toft</name></author><author><name sortKey="Overgaard, M" uniqKey="Overgaard M">M Overgaard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mutrie, N" uniqKey="Mutrie N">N Mutrie</name></author><author><name sortKey="Campbell, Am" uniqKey="Campbell A">AM Campbell</name></author><author><name sortKey="Whyte, F" uniqKey="Whyte F">F Whyte</name></author><author><name sortKey="Mcconnachie, A" uniqKey="Mcconnachie A">A McConnachie</name></author><author><name sortKey="Emslie, C" uniqKey="Emslie C">C Emslie</name></author><author><name sortKey="Lee, L" uniqKey="Lee L">L Lee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Beurskens, Ch" uniqKey="Beurskens C">CH Beurskens</name></author><author><name sortKey="Van Uden, Cj" uniqKey="Van Uden C">CJ van Uden</name></author><author><name sortKey="Strobbe, Lj" uniqKey="Strobbe L">LJ Strobbe</name></author><author><name sortKey="Oostendorp, Ra" uniqKey="Oostendorp R">RA Oostendorp</name></author><author><name sortKey="Wobbes, T" uniqKey="Wobbes T">T Wobbes</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article" xml:lang="en"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Womens Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Womens Health</journal-id><journal-title-group><journal-title>BMC Women's Health</journal-title></journal-title-group><issn pub-type="epub">1472-6874</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23406386</article-id><article-id pub-id-type="pmc">3577444</article-id><article-id pub-id-type="publisher-id">1472-6874-13-6</article-id><article-id pub-id-type="doi">10.1186/1472-6874-13-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Paiva</surname><given-names>Daniella MF</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jcndani@yahoo.com.br</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Rodrigues</surname><given-names>Vivian O</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>viviolliver@hotmail.com</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Cesca</surname><given-names>Marcelle G</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>marcelle.goldner@gmail.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Palma</surname><given-names>Pamella V</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>pamellavalente@hotmail.com</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Leite</surname><given-names>Isabel CG</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>icgleite@hotmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>School of Medical Sciences and Health, Juiz de Fora, Brazil</aff><aff id="I2"><label>2</label>School of Medicine, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</aff><aff id="I3"><label>3</label>School of Dentistry, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, Juiz de Fora, Brazil</aff><aff id="I4"><label>4</label>Public Health Department of the School of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>13</day><month>2</month><year>2013</year></pub-date><volume>13</volume><fpage>6</fpage><lpage>6</lpage><history><date date-type="received"><day>7</day><month>6</month><year>2012</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2013</year></date></history><permissions><copyright-statement>Copyright ©2013 Paiva et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Paiva et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1472-6874/13/6"></self-uri><abstract><sec><title>Background</title><p>Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.</p></sec><sec><title>Methods</title><p>We performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded. Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment.</p></sec><sec><title>Results</title><p>The prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in 5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).</p></sec><sec><title>Conclusions</title><p>The prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the morbidity of this disease.</p></sec></abstract><kwd-group><kwd>Lymphedema</kwd><kwd>Risk factors</kwd><kwd>Cross-seccional study</kwd><kwd>Prevalence</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Breast cancer is considered the second leading cause of mortality and morbidity among women in Brazil [<xref ref-type="bibr" rid="B1">1</xref>]. The approaches used to control and treat breast cancer have been well studied to the extent that they have led to increased survival of these women [<xref ref-type="bibr" rid="B2">2</xref>]. Therefore, there is growing interest in seeking resources and alternatives that could improve the quality of life of breast cancer patients [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. There is also a need to understand the behavior of morbidities from breast cancer that may occur because of tumor development and the therapies used. There is still a high number of late diagnoses that contribute to the election of more aggressive therapy and subsequent traumatic surgery [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. This necessitates the improvement of therapeutic techniques to reduce the number of comorbidities presented. Among the notable major innovations are breast surgery techniques and axillary approaches, such as sentinel lymph node (SLN) biopsy [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. Even with the use of these approaches, studies show a high prevalence of postoperative morbidities, mainly regarding lymphedema [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. This condition arises from disruption of the lymphatic system in coping with the axillary approach for staging or control of the disease [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Recent studies on the prevalence of lymphedema and associated factors in specific populations show varying results [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>] possibly owing to differing diagnostic methods for detection of lymphedema and to sampling differences. Improving the knowledge regarding risk factors specifically associated with lymphedema in a given population will aid in the formulation of protocols for both its prevention and its treatment, enabling an improved quality of life for these women.</p><p>In the municipality of Juiz de Fora, Minas Gerais, southeastern Brazil, there are cancer treatment centers extending services to neighboring micro and macro regions, thus offering a potent sampling source for research in the area.</p><p>This study aimed to ascertain the prevalence of lymphedema in women undergoing treatment for breast cancer in a referral unit for cancer treatment in the municipality of Juiz de Fora, as well as associated risk factors. We hypothesized that the prevalence of lymphedema is high and is associated with the time elapsed since surgery and comorbidities among these women.</p></sec><sec sec-type="methods"><title>Methods</title><p>During the period from August 2009 to June 2010, a total of 250 women, who came to the clinic for an oncology (chemotherapy and/or radiotherapy) follow-up visit, were evaluated at a specialized hospital in the municipality of Juiz de Fora. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders.</p><p>All eligible women were invited to participate in the study, and upon signing the consent form, only four women refused to participate. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded.</p><p>Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment. Records were analyzed to obtain data regarding the treatment of breast cancer, axillary intervention, seromas, vascular implications, and tumor staging. A semi-structured questionnaire was used for subjective diagnosis of lymphedema and its possible associated factors, followed by the administration of a physical examination for clinical diagnosis and detection of co-existing morbidities. The elapsed time from surgery until the date of the interview was divided into two categories: beyond or within 5 years. Current pain was estimated using the Visual Analog Scale categorized into 10 recording intervals for de-registration.</p><p>The physical examination was performed by only one evaluator, who was qualified and trained for this type of approach. The criterion for the diagnosis of lymphedema was obtained by perimetry with the use of a measuring tape, with measurements obtained after adjustment of the dominant arm and time since diagnosis [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Measurements were taken at seven points: at the inside of the elbow in the supine position (taken as the zero point), and three measurements above and below this point, at intervals of 7.0 cm. Lymphedema was characterized as when the difference between the affected limb and the contralateral (control) limb, using at least one measurement, was equal to or greater than 2.0 cm [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. This study met the requirements of the Declaration of Helsinki and was approved by the Institutional Ethics Committee of the Federal University of Juiz de Fora (reference number: 050/2009).</p><sec><title>Statistical analysis</title><p>The data were processed in a database created with the Statistical Package for Social Sciences version 14.0 (SPSS Inc., Chicago, IL) and Stata 10.0 (StataCorp, Texas). The significance level of the study was 95% (p≤0.05). The presence or absence of lymphedema was considered the dependent variable. The independent variables were aggregated and analyzed in blocks, combined with socio-demographic and health self-assessment variables, characteristics concerning the diagnosis and treatment of cancer, symptoms and presence of Axillary Web Syndrome (AWS) or superficial lymphatic thrombosis in the upper limb ipsilateral to surgery in the postoperative period, information regarding the care and early movement of the limb ipsilateral to surgery, and variables associated with lymphedema in women after surgical treatment of breast cancer. These factors were adjusted for variables on self-reported morbidities, treatment characteristics, and postoperative characteristics. Descriptive analysis was used to obtain absolute and relative frequencies of the analysis variables, as well as for the prevalence of the outcome investigated. Bivariate analysis was performed to assess the association of each independent variable with the dependent variable, using the chi-square (χ<sup>2</sup>) test. In multivariate analysis, Poisson regression was used to analyze the independent variables associated with outcome, controlling for potential confounders, such as the dominant arm and time since diagnosis (adjusted prevalence ratio). The Poisson regression in each block of analysis combined variables with a crude p-value <0.20, and between the blocks, the adopted significance was 5%. The significance level was tested using the Wald test for heterogeneity and linear trend.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The prevalence of lymphedema in the upper limb ipsilateral to breast surgery was 44.8% (112/250 women). There were medical records on the presence of this condition in 5.4% of cases (6/250 cases). The time elapsed after surgery was significantly associated with the prevalence of lymphedema (p=0.028).</p><p>With regard to variables from the postoperative period, the presence of seroma and symptoms, such as redness, were significantly associated with lymphedema (p<0.001) after adjustment by the regression model (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Symptoms and presence of AWS in the arm ispilateral to the surgery, Brazil, 2010</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col></colgroup><thead valign="top"><tr><th align="center"> </th><th align="center"><bold>Variables</bold></th><th align="center"><bold>%</bold></th><th align="center"><bold><italic>P</italic></bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Presence of seroma<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">25.0<hr></hr></td><td align="center" valign="bottom"><0.001<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">75.0<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Heat Sensation in the scar<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">73.2<hr></hr></td><td align="center" valign="bottom">0.05<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">26.8<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Pain in the scar<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">48.2<hr></hr></td><td align="center" valign="bottom">0.013<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">51.8<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Heat sensation in the upper limb<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">63.4<hr></hr></td><td align="center" valign="bottom">0.015<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">36.6<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Pain in any part of the upper limb<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">27.7<hr></hr></td><td align="center" valign="bottom"><0.001<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">72.3<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Burning sensation in any part of the upper limb<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">69.6<hr></hr></td><td align="center" valign="bottom">0.012<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">30.4<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Episode of redness in any part of the upper limb<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">66.1<hr></hr></td><td align="center" valign="bottom"><0.01<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">33.9<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Presence of lymphatic cord - AWS, anywhere in the upper limb<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">35.7<hr></hr></td><td align="center" valign="bottom"><0.01<hr></hr></td></tr><tr><td align="center"> </td><td align="center">Yes</td><td align="center">63.4</td><td align="center"> </td></tr></tbody></table><table-wrap-foot><p>Variables related to variables for women, such as symptoms and presence of AWS in the arm ispilateral to the surgery in the postoperative period, associated with lymphedema following surgical treatment for breast cancer, Juiz de Fora (MG), Brazil, 2010.</p></table-wrap-foot></table-wrap><p>Physical examination showed that 49.6% (124/250) of the women with lymphedema had superficial lymphatic thrombosis, which demonstrated an association with lymphedema in bivariate analysis (p<0.001).</p><p>The mean age of patients with lymphedema was 56±11,58 and there was no significant difference in age compared with those without lymphedema (p=0.24). The two groups were similar with respect to variables, such as schooling (p=0.39), obesity (p=0.35), and skin color (p=0.15). In the presence of comorbidities, women with vascular implications (thrombosis, varicose veins, circulatory changes in the lower and/or upper limbs, and others) had a frequency of 2.7 times greater for developing lymphedema (p=0.02). There was no difference between the groups for other self-reported health conditions, including hypertension (p=0.30) and diabetes mellitus (p=0.49, Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Women’s socio-demographic and self-reported health characteristics, Brazil, 2010</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col></colgroup><thead valign="top"><tr><th align="center"><bold>Variable</bold></th><th align="center"><bold>Variable category</bold></th><th align="center"><bold>%</bold></th><th align="center"><bold>Crude PR (CI 95%)</bold></th><th align="center"><bold><italic>p</italic></bold></th><th align="center"><bold>Adjusted PR</bold><sup><bold>a</bold></sup><bold>(CI 95%)</bold></th><th align="center"><bold><italic>p</italic></bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Age<hr></hr></td><td align="center" valign="bottom">up to 56 years<hr></hr></td><td align="center" valign="bottom">49.1<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.17<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.20<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">57–75 years<hr></hr></td><td align="center" valign="bottom">50.9<hr></hr></td><td align="center" valign="bottom">1.30(0.79–2.15)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.40(0.79–2.45)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Skin color<hr></hr></td><td align="center" valign="bottom">non-White<hr></hr></td><td align="center" valign="bottom">59.8<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.05<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.15<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">White<hr></hr></td><td align="center" valign="bottom">40.2<hr></hr></td><td align="center" valign="bottom">1.58(0.94–2.68)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.51(0.85–2.66)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Schooling<hr></hr></td><td align="center" valign="bottom">Secondary/higher<hr></hr></td><td align="center" valign="bottom">37.5<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.13<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.39<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Primary<hr></hr></td><td align="center" valign="bottom">52.7<hr></hr></td><td align="center" valign="bottom">1.18(0.70–2.00)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.78(0.55–5.72)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Illiterate<hr></hr></td><td align="center" valign="bottom">9.8<hr></hr></td><td align="center" valign="bottom">2.24(0.80–6.26)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.61(0.54–4.79)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Obesity<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">70.5<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.19<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.35<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">29.5<hr></hr></td><td align="center" valign="bottom">1.31(0.77–2.25)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.31(0.74–2.32)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Vascular changes<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">95.5<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.00<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.02<hr></hr></td></tr><tr><td align="center"> </td><td align="center">Yes</td><td align="center">4.5</td><td align="center">3.84(1.39–10.54)</td><td align="center"> </td><td align="center">3.67(1.22–1.11)</td><td align="center"> </td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Variables adjusted within their blocks.</p><p>Women’s socio-demographic and self-reported health characteristics, associated with the occurence of lymphedema following surgical treatment for breast cancer, Juiz de Fora (MG), \Brazil, 2010.</p></table-wrap-foot></table-wrap><p>Women who had undergone surgery more than 5 years previously had a 9.7 times higher frequency of lymphedema compared with those who had undergone surgery less than 5 years previously (p=0.02). The analysis of other variables related to cancer treatment is shown in Table <xref ref-type="table" rid="T3">3</xref>.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Characteristics regarding the diagnosis and treatment of cancer in women, Brazil, 2010</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col></colgroup><thead valign="top"><tr><th align="center"> </th><th align="center"><bold>Variables</bold></th><th align="center"><bold>%</bold></th><th align="center"><bold>Crude PR(CI 95%)</bold></th><th align="center"><bold><italic>p</italic></bold></th><th align="center"><bold>Adjusted PR</bold><sup><bold>a</bold></sup><bold>(CI 95%)</bold></th><th align="center"><bold><italic>p</italic></bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Staging<hr></hr></td><td align="center" valign="bottom">0–2<hr></hr></td><td align="center" valign="bottom">46.4<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.001<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.216<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">3–4<hr></hr></td><td align="center" valign="bottom">43.8<hr></hr></td><td align="center" valign="bottom">2.23(1.33–3.72)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.15(0.78–2.92)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Type of surgery (breast)<hr></hr></td><td align="center" valign="bottom">Conservative<hr></hr></td><td align="center" valign="bottom">40.2<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.04<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.91<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Radical<hr></hr></td><td align="center" valign="bottom">59.8<hr></hr></td><td align="center" valign="bottom">0.63(0.38–1.04)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">0.96(0.45–2.00)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Level of axillary lymphadenectomy<hr></hr></td><td align="center" valign="bottom">Sampling<hr></hr></td><td align="center" valign="bottom">6.3<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom"><0.01<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.52<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Dissection-low<hr></hr></td><td align="center" valign="bottom">42.0<hr></hr></td><td align="center" valign="bottom">3.76(1.50–9.42)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.81(0.53–6.17)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Dissection-high<hr></hr></td><td align="center" valign="bottom">35.7<hr></hr></td><td align="center" valign="bottom">4.44(1.73–11.40)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.42(0.39–5.18)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Chemotheraphy performed<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">11.6<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom"><0.01<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.69<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">87.5<hr></hr></td><td align="center" valign="bottom">3.22(1.62–6.38)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">4.71(0.62–5.74)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Any chemotherapy performed on arm ipsilateral to surgery<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">74.1<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.11<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.91<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">11.6<hr></hr></td><td align="center" valign="bottom">2.01(0.76–5.29)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.06(0.34–3.33)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Radiotherapy performed<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">9.8<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.478<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">90.2<hr></hr></td><td align="center" valign="bottom">1.12(0.49–2.54)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Area administered radiotherapy<hr></hr></td><td align="center" valign="bottom">Biopsy<hr></hr></td><td align="center" valign="bottom">56.3<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.008<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.13<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Axilla-breast<hr></hr></td><td align="center" valign="bottom">28.6<hr></hr></td><td align="center" valign="bottom">2.67(1.27–5.59)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">2.83(0.93–8.56)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center"> </td><td align="center">Breast, axilla, supraclavicular fossa</td><td align="center">15.2</td><td align="center">2.66(1.17–6.02)</td><td align="center"> </td><td align="center">1.52(0.47–4.86)</td><td align="center"> </td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Variables adjusted within their blocks.</p><p>Characteristics regarding the diagnosis and treatment of cancer in women, associated with the occurence of lymphedema following surgical treatment for breast cancer, Juiz de Fora (MG), Brazil, 2010.</p></table-wrap-foot></table-wrap><p>With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema (p<0.001).</p><p>There was no significant association with outcome for almost all of the variables related to information that the patients received from the healthcare team on caring for their limbs and guidance on early movement after surgery, except for the variable of cuticle removal from the hand with pliers. This variable remained associated with lymphedema even when adjusted for other variables, such as self-reported morbidities and characteristics of the implemented treatment (p=0.02, Table <xref ref-type="table" rid="T4">4</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Care and early movement of the limb ipsilateral to surgery in women, Brazil, 2010</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col></colgroup><thead valign="top"><tr><th align="center"> </th><th align="center"><bold>Variables</bold></th><th align="center"><bold>%</bold></th><th align="center"><bold>Crude PR (CI 95%)</bold></th><th align="center"><bold><italic>p</italic></bold></th><th align="center"><bold>Adjusted PR</bold><sup><bold>a</bold></sup><bold>(CI 95%)</bold></th><th align="center"><bold><italic>p</italic></bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Removing hand cuticles with pliers<hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">40.2<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.06<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.02<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">59.8<hr></hr></td><td align="center" valign="bottom">1.53 (0.92–25)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">2.10(1.11–3.95)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Armpit depilation by razor blade or waxing<hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">34.8<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.10<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.81<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">65.2<hr></hr></td><td align="center" valign="bottom">1.43 (0.86–2.41)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.13(0.39–3.31)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Carry weight with the affected limb<hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">60.7<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.09<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.54<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">39.3<hr></hr></td><td align="center" valign="bottom">1.47(0.84–20.40)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.307(0.54–3.11)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Receive vaccines and/or injections in the limb<hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">54.5<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.08<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.96<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">45.5<hr></hr></td><td align="center" valign="bottom">1.47(0.88–20.40<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.02(0.39–2.63)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Injury/burn in any part of the limb<hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">36.6<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.04<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.32<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">63.4<hr></hr></td><td align="center" valign="bottom">1.58(0.95–2.63)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.84(0.54–6.28)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Guidance on exercising in the postoperative period<hr></hr></td><td align="center" valign="bottom">First day until first month<hr></hr></td><td align="center" valign="bottom">22.3<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.05<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.12<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">After losing movement<hr></hr></td><td align="center" valign="bottom">23.2<hr></hr></td><td align="center" valign="bottom">0.67(0.34–1.31)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">1.25(0.61–2.54)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center"> </td><td align="center">Didn’t receive guidance</td><td align="center">54.5</td><td align="center">(1.67(0.92–3.02)</td><td align="center"> </td><td align="center">1.94(0.91–4.18)</td><td align="center"> </td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Variables adjusted within their blocks.</p><p>Variables related to the clarification received regarding the care and early movement of the limb ipsilateral to surgery in women, associated with lymphedema following surgical treatment for breast cancer Juiz de Fora (MG), Brazil, 2010.</p></table-wrap-foot></table-wrap><p>All variables that proved to be significant after adjustment within the block to which they belonged were subjected to Poisson regression to build the final model. Variables that remained significant were vascular disorders (p=0.08), the presence of redness in any region of the arm after surgery (p<0.001), the presence of seroma (p<0.001), and cuticle removal with pliers from the hand corresponding to the limb ipsilateral to surgery (p=0.013), because actual daily routine remained relevant in the model (Table <xref ref-type="table" rid="T5">5</xref>).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Variables associated with lymphedema in women after surgical treatment of breast cancer, Brazil, 2010</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col></colgroup><thead valign="top"><tr><th align="center"> </th><th align="center"><bold>Variables</bold></th><th align="center"><bold>%</bold></th><th align="center"><bold>Crude PR (CI 95%)</bold></th><th align="center"><bold><italic>p</italic></bold></th><th align="center"><bold>Adjusted PR (CI 95%)</bold><sup><bold>a</bold></sup></th><th align="center"><bold><italic>p</italic></bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Vascular pathologies<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">95.5<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.02<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.08<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">4.5<hr></hr></td><td align="center" valign="bottom">3.67(1.22–11.11)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">3.23(1.06–9.90)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Seroma<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">25.0<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom"><0.01<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom"><0.01<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">75.0<hr></hr></td><td align="center" valign="bottom">3.01(1.61–5.62)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">2.71(1.49–4.91)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Arm redness<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">66.1<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.01<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom"><0.01<hr></hr></td></tr><tr><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">Yes<hr></hr></td><td align="center" valign="bottom">33.9<hr></hr></td><td align="center" valign="bottom">8.11(2.20–29.93)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td><td align="center" valign="bottom">3.63(1.67–7.87)<hr></hr></td><td align="center" valign="bottom"> <hr></hr></td></tr><tr><td align="center" valign="bottom">Cuticle removal<hr></hr></td><td align="center" valign="bottom">No<hr></hr></td><td align="center" valign="bottom">33.9<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.01<hr></hr></td><td align="center" valign="bottom">1<hr></hr></td><td align="center" valign="bottom">0.01<hr></hr></td></tr><tr><td align="center"> </td><td align="center">Yes</td><td align="center">66.1</td><td align="center">2.10(1.116–3.95)</td><td align="center"> </td><td align="center">2.07(1.16–3.71)</td><td align="center"> </td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> Adjusted between blocks.</p><p>Variables associated with lymphedema in women after surgical treatment of breast cancer, after adjustments for variables on self-reported morbidities, treatment characteristics, and postoperative characteristics. Juiz de Fora (MG), Brazil, 2010.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>The current study found that the prevalence of patients with lymphedema after treatment for breast cancer was 44.8%. However, it is possible that underestimation occurred because the average time spent in the postoperative period in our sample was 5 years, and the higher a woman’s exposure to risk factors, the greater the chances of developing lymphedema. The possibility of survival bias cannot be ruled out because more severe cases subjected to more drastic measures may not have maintained contact owing to death, and therefore were not included in this sample. The prevalence of lymphedema found in this study is higher than the prevalence rates between 9% and 40% reported by other studies [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. This difference between prevalence rates could be attributed to the type of method used to diagnose lymphedema, because there are several methods for measuring arm volume, [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B19">19</xref>] and because of the fact that the institution in which the data were collected does not offer a service specializing in prevention and treatment of lymphedema. Perimetry, which was the diagnostic method used in this study, is based on comparing the measurement of the circumference of the affected arm with the contralateral arm [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Furthermore, in Brazil, delayed diagnosis is common, causing more aggressive surgeries, which could be an important reason for the high prevalence of lymphedema in this study.</p><p>Age is a variable often associated with lymphedema [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B22">22</xref>]. Along with the aging process, anatomical and physiological changes related to lymphatic obstruction occur, which may predispose to the development of lymphedema, with the main mechanism being the opening of lympho-venous anastomoses [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. The higher incidence of lymphedema in older patients observed in some studies [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>] may be due to a progressive loss of these anastomoses because of the aging process [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. This finding was not observed in the current study, where the average age of the patients with lymphedema was 56 years, with no significant difference between those with and those without lymphedema. Likewise, a study by Yen et al., [<xref ref-type="bibr" rid="B20">20</xref>] who investigated self-reporting of the risk factors for lymphedema in older women, also found no significant difference between women with and those without lymphedema. The difference in evaluation methods and the average age of the women involved in these studies may be responsible for the discrepancy of results.</p><p>In attempting to reestablish the lympho-venous balance of the upper limb and breast region after breast cancer treatment, the body makes use of compensatory mechanisms, which attempt to avoid edema. However, some factors such as trauma, aging, and repetitive or non-repetitive episodes of infections can overwhelm the lymphatic system, changing the balance. Therefore, the longer the time elapsed since surgery, the greater the risk of developing lymphedema, because this increases the chances of a woman being exposed to injury [<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Radiotherapy is considered as a risk factor for development of lymphedema, mainly when axillary irradiation is applied [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. A likely explanation is the occurrence of lymphedema due to the blockage of lymph vessels or their compression by fibrosis caused by this treatment [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. According to Bergmann et al., [<xref ref-type="bibr" rid="B7">7</xref>] the main risk factor associated with lymphedema after treatment for breast cancer is the axillary approach, both surgical and radiotherapy, followed by age. Our study differs from previous studies in that there was no association between the irradiation site and the development of morbidity when controlled by other variables.</p><p>AWS, otherwise known as superficial lymphatic thrombosis, is the formation of a palpable network of cords that can extend from the armpit, through the antecubital space to the base of the thumb. AWS is caused by possible formation and displacement of fibrin clots in the superficial veins and lymphatic capillaries, which form a network [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. In the current study, the presence of AWS in bivariate analysis was statistically significant (p<0.001). However, when AWS was analyzed in the adjusted model, it lost its significance. This syndrome is accompanied by acute pain symptoms that may regress spontaneously (~3 months after surgery) or become chronic, when the formation of a fibrotic cord occurs, and this restricts the range of motion of the shoulder [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. The presence of AWS contributes to the formation or worsening of lymphedema [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B31">31</xref>].</p><p>Some studies question the validity of current guideline “manuals” for the prevention of lymphedema, because they believe that despite the biological plausibility, no evidence has been shown for the validity of these treatments [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. Therefore, it is prudent for the patient to take certain care of the arm, but this should not affect or impair the patient’s daily routine. The occurrence of minor injuries, such as cuts, bruises, minor burns, and infection, triggers an inflammatory response. This translates into an increase of fluid filtered by the arterial capillaries into the interstitium, capillaries and lymphatic vessels, which overloads the lymphatic system already damaged by lymphadenectomy [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. This process may intensify, generating local symptoms, as well as general symptoms, giving rise to the appearance of erysipelas and/or lymphangitides [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. The removal of cuticles during nail care allows easy access to bacteria, by producing a skin lesion, facilitating an inflammatory process that can precede or aggravate lymphedema [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B26">26</xref>].</p><p>The prevalence of moderate to severe symptoms in women who avoid movement of the ipsilateral arm after surgery is significantly higher than in those who do not avoid it. These data are corroborated by several studies [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B20">20</xref>] in which changes in movements of the shoulder after surgery for breast cancer were investigated, at various times after surgery, to determine the effect of early exercise intervention through physiotherapy [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. In the present study, only 119 women (47.6%) received some type of information concerning various treatments for the limb and the importance of early motion. In this case, besides harm from the lack of intervention supervised by a professional, the guidance of self care alone leads to misinterpretation, resulting in failure to perform adequate exercises. Studies of lymphedema have shown a positive association between the receipt of information and the avoidance of movement [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. In our study, an important association was found between lymphedema and the lack of information regarding movement of the limb, although this was not statistically significant in multivariate analysis.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Lymphedema is a multifactorial morbidity. Therefore, an interdisciplinary approach is required. The prevalence of 44.8% for lymphedema found in this study is considered relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. Lymphedema is associated with the time elapsed after surgery, associated vascular pathologies, the presence of seroma, episodes of redness in some parts of the limb after surgery, and cuticle removal with pliers from the hand ipsilateral to the surgery. The surgical method, as well as the extent of the axillary approach, the area administered radiotherapy, and application of chemotherapy show a positive, but not significant, association with the presence of lymphedema.</p><p>We conclude that lymphedema is a preventable morbidity. The planning of health programs and services appropriate to the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize morbidity. Understanding and improved definitions of the associated factors could be important tools for treatment of this condition.</p></sec><sec><title>Abbreviations</title><p>AWS: Axillary Web Syndrome; SLN: Sentinel lymph node.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing financial interests.</p></sec><sec><title>Authors’ contributions</title><p>DMFP conceived the study and participated in the study design, analysis, and drafting of the manuscript. VOR, MGC, and PVP participated in the study design, and performed statistical analysis and data collection. ICG participated in the study design, coordination, and analysis, and drafting of the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Authors’ information</title><p>DMFP is a professor at the School of Medical Sciences and Health, Juiz de Fora, SUPREMA, Brazil. VOR is a graduate student at the School of Medicine, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, UFJF, Brazil. MGC is a graduate student at the School of Medicine, Institutional Programs for Scientific Start-up Grants (XXII BIC/UFJF), Federal University of Juiz de Fora, UFJF, Brazil. PVP is a graduate student at the School of Dentistry, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, UFJF, Brazil. ICG has a doctorate in public health, and is an adjunct professor of the Public Health Department of the School of Medicine, Federal University of Juiz de Fora, UFJF, Brazil.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-6874/13/6/prepub">http://www.biomedcentral.com/1472-6874/13/6/prepub</ext-link></p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="book"><collab>Ministério da Saúde (Brasil). Instituto Nacional de Câncer</collab><source>Estimativas da Incidência e mortalidade por Câncer no Brasil</source><year>2010</year><publisher-name>Rio de Janeiro: INCA</publisher-name></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Guerra</surname><given-names>MR</given-names></name><name><surname>Mendonça</surname><given-names>GAS</given-names></name><name><surname>Bustamante-Teixeira</surname><given-names>MT</given-names></name><name><surname>Cintra</surname><given-names>JRD</given-names></name><name><surname>Carvalho</surname><given-names>LM</given-names></name><name><surname>Magalhães</surname><given-names>LMPV</given-names></name><article-title>Sobrevida de cinco anos e fatores prognósticos em coorte de pacientes com câncer de mama assistidas em Juiz de Fora, Minas Gerais</article-title><source>Brasil. Cad Saúde Publica</source><year>2009</year><volume>25</volume><fpage>2455</fpage><lpage>2466</lpage><pub-id pub-id-type="doi">10.1590/S0102-311X2009001100015</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Beaulac</surname><given-names>SM</given-names></name><name><surname>McNair</surname><given-names>LA</given-names></name><name><surname>Scott</surname><given-names>TE</given-names></name><name><surname>LaMorte</surname><given-names>WW</given-names></name><name><surname>Kavanah</surname><given-names>MT</given-names></name><article-title>Lymphedema and quality of life in survivors of early-stage breast cancer</article-title><source>Arch Surg</source><year>2002</year><volume>137</volume><fpage>1253</fpage><lpage>1257</lpage><pub-id pub-id-type="doi">10.1001/archsurg.137.11.1253</pub-id><pub-id pub-id-type="pmid">12413312</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Dayes</surname><given-names>IS</given-names></name><name><surname>Levine</surname><given-names>MN</given-names></name><name><surname>Julian</surname><given-names>JA</given-names></name><name><surname>Pritchard</surname><given-names>KI</given-names></name><name><surname>D’Souza</surname><given-names>DP</given-names></name><name><surname>Kligman</surname><given-names>L</given-names></name><etal></etal><article-title>Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial</article-title><source>Breast Cancer Res Treat</source><year>2008</year><volume>110</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1007/s10549-007-9727-0</pub-id><pub-id pub-id-type="pmid">17851756</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Sampaio</surname><given-names>EBM</given-names></name><name><surname>Albuquerque</surname><given-names>IMAN</given-names></name><name><surname>Linhares</surname><given-names>JJ</given-names></name><article-title>Assessing the quality of life in women with breast cancer through the questionnaire SF-36</article-title><source>Appl Cancer Res</source><year>2008</year><volume>28</volume><fpage>93</fpage><lpage>98</lpage></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Engel</surname><given-names>J</given-names></name><name><surname>Kerr</surname><given-names>J</given-names></name><name><surname>Schlesinger-Raab</surname><given-names>A</given-names></name><name><surname>Sauer</surname><given-names>H</given-names></name><name><surname>Hölzel</surname><given-names>D</given-names></name><article-title>Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients</article-title><source>Breast Cancer Res Treat</source><year>2003</year><volume>79</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1023/A:1023330206021</pub-id><pub-id pub-id-type="pmid">12779081</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Bergmann</surname><given-names>A</given-names></name><name><surname>Mattos</surname><given-names>IE</given-names></name><name><surname>Koiffman</surname><given-names>RJ</given-names></name><name><surname>Ribeiro</surname><given-names>MJP</given-names></name><article-title>Upper limb lymphedema following breast cancer surgery: prevalence and associated factors</article-title><source>Lymphology</source><year>2008</year><volume>40</volume><issue>Suppl</issue><fpage>96</fpage><lpage>106</lpage></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Buchholz</surname><given-names>T</given-names></name><name><surname>Avristscher</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>TK</given-names></name><article-title>Identifying the “sentinel lymph nodes” for arm drainage as strategy for minimizing the lymphedema risk after breast cancer therapy</article-title><source>Breast Cancer Res Treat</source><year>2009</year><volume>116</volume><fpage>539</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1007/s10549-009-0324-2</pub-id><pub-id pub-id-type="pmid">19184413</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Stanton</surname><given-names>AW</given-names></name><name><surname>Modi</surname><given-names>S</given-names></name><name><surname>Mellor</surname><given-names>RH</given-names></name><name><surname>Levick</surname><given-names>JR</given-names></name><name><surname>Mortimer</surname><given-names>PS</given-names></name><article-title>Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors</article-title><source>Lymphat Res Biol</source><year>2009</year><volume>7</volume><fpage>29</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1089/lrb.2008.1026</pub-id><pub-id pub-id-type="pmid">19302022</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Armer</surname><given-names>JM</given-names></name><name><surname>Stewart</surname><given-names>BR</given-names></name><article-title>Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months</article-title><source>Lymphology</source><year>2010</year><volume>43</volume><fpage>118</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">21226414</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Gartner</surname><given-names>R</given-names></name><name><surname>Jesse</surname><given-names>MB</given-names></name><name><surname>Kronborg</surname><given-names>L</given-names></name><name><surname>Ewertz</surname><given-names>M</given-names></name><name><surname>Kehlet</surname><given-names>H</given-names></name><collab>Kromann</collab><article-title>Self-reported arm-lymphedema and impairment after breast cancer treatment – a national study of prevalence and associated factors</article-title><source>Breast</source><year>2010</year><volume>19</volume><fpage>506</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.breast.2010.05.015</pub-id><pub-id pub-id-type="pmid">20561790</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Deo</surname><given-names>SV</given-names></name><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Rath</surname><given-names>GK</given-names></name><name><surname>Shukla</surname><given-names>NK</given-names></name><name><surname>Kar</surname><given-names>M</given-names></name><name><surname>Asthana</surname><given-names>S</given-names></name><etal></etal><article-title>Prevalence and risk factors for development of lymphedema following breast cancer treatment</article-title><source>Indian J Cancer</source><year>2004</year><volume>41</volume><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15105573</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="other"><name><surname>Soran</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>WC</given-names></name><name><surname>Dirican</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Andacoglu</surname><given-names>O</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name><article-title>Estimating the probability of lymphedema after breast cancer surgery</article-title><source>Am J Clin Oncol</source><year>2010</year><comment>Epub ahead of print</comment></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Norman</surname><given-names>SA</given-names></name><name><surname>Localio</surname><given-names>AR</given-names></name><name><surname>Potashnik</surname><given-names>SL</given-names></name><name><surname>Simoes Torpey</surname><given-names>HA</given-names></name><name><surname>Kallan</surname><given-names>MJ</given-names></name><name><surname>Weber</surname><given-names>AL</given-names></name><etal></etal><article-title>Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms</article-title><source>J Clin Oncol</source><year>2009</year><volume>27</volume><fpage>390</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">19064976</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Kwan</surname><given-names>ML</given-names></name><name><surname>Darbinian</surname><given-names>J</given-names></name><name><surname>Schmitz</surname><given-names>KH</given-names></name><name><surname>Citron</surname><given-names>R</given-names></name><name><surname>Partee</surname><given-names>P</given-names></name><name><surname>Kutner</surname><given-names>SE</given-names></name><etal></etal><article-title>Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study</article-title><source>Arch Surg</source><year>2010</year><volume>145</volume><fpage>1055</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1001/archsurg.2010.231</pub-id><pub-id pub-id-type="pmid">21079093</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Hayes</surname><given-names>SC</given-names></name><name><surname>Janda</surname><given-names>M</given-names></name><name><surname>Cornish</surname><given-names>B</given-names></name><name><surname>Battistutta</surname><given-names>D</given-names></name><name><surname>Newman</surname><given-names>B</given-names></name><article-title>Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function</article-title><source>J Clin Oncol</source><year>2008</year><volume>26</volume><fpage>3536</fpage><lpage>3542</lpage><pub-id pub-id-type="doi">10.1200/JCO.2007.14.4899</pub-id><pub-id pub-id-type="pmid">18640935</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Hunt</surname><given-names>KK</given-names></name><name><surname>Askew</surname><given-names>R</given-names></name><name><surname>Cormier</surname><given-names>JN</given-names></name><article-title>Measuring lymphedema in patients with breast cancer: go with the flow?</article-title><source>Breast Cancer Res Treat</source><year>2009</year><volume>117</volume><fpage>559</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1007/s10549-009-0320-6</pub-id><pub-id pub-id-type="pmid">19205875</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Cormier</surname><given-names>JN</given-names></name><name><surname>Askew</surname><given-names>RL</given-names></name><name><surname>Mungovan</surname><given-names>KS</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Ross</surname><given-names>MI</given-names></name><name><surname>Armer</surname><given-names>JM</given-names></name><article-title>Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema</article-title><source>Cancer</source><year>2010</year><volume>116</volume><fpage>5138</fpage><lpage>5149</lpage><pub-id pub-id-type="doi">10.1002/cncr.25458</pub-id><pub-id pub-id-type="pmid">20665892</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Thomas-Maclean</surname><given-names>RL</given-names></name><name><surname>Hack</surname><given-names>T</given-names></name><name><surname>Kwan</surname><given-names>W</given-names></name><name><surname>Towers</surname><given-names>A</given-names></name><name><surname>Miedema</surname><given-names>B</given-names></name><name><surname>Tilley</surname><given-names>A</given-names></name><article-title>Arm morbidity and disability after breast cancer: new directions for care</article-title><source>Oncol Nurs Forum</source><year>2008</year><volume>35</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1188/08.ONF.65-71</pub-id><pub-id pub-id-type="pmid">18192154</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Tsai</surname><given-names>RJ</given-names></name><name><surname>Dennis</surname><given-names>LK</given-names></name><name><surname>Lynch</surname><given-names>CF</given-names></name><name><surname>Snetselaar</surname><given-names>LG</given-names></name><name><surname>Zamba</surname><given-names>GK</given-names></name><name><surname>Scott-Conner</surname><given-names>C</given-names></name><article-title>The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors</article-title><source>Ann Surg Oncol</source><year>2009</year><volume>16</volume><fpage>1959</fpage><lpage>1972</lpage><pub-id pub-id-type="doi">10.1245/s10434-009-0452-2</pub-id><pub-id pub-id-type="pmid">19365624</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Yen</surname><given-names>TW</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Sparapani</surname><given-names>R</given-names></name><name><surname>Laud</surname><given-names>PW</given-names></name><name><surname>Walker</surname><given-names>AP</given-names></name><name><surname>Nattinger</surname><given-names>AB</given-names></name><article-title>A contemporary, population-based study of lymphedema risk factors in older women with breast cancer</article-title><source>Ann Surg Oncol</source><year>2009</year><volume>16</volume><fpage>979</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1245/s10434-009-0347-2</pub-id><pub-id pub-id-type="pmid">19194754</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Shih</surname><given-names>YC</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Cormier</surname><given-names>JN</given-names></name><name><surname>Giordano</surname><given-names>S</given-names></name><name><surname>Ridner</surname><given-names>SH</given-names></name><name><surname>Buchholz</surname><given-names>TA</given-names></name><etal></etal><article-title>Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study</article-title><source>J Clin Oncol</source><year>2009</year><volume>27</volume><fpage>2007</fpage><lpage>2014</lpage><pub-id pub-id-type="doi">10.1200/JCO.2008.18.3517</pub-id><pub-id pub-id-type="pmid">19289624</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Harmer</surname><given-names>V</given-names></name><article-title>Breast cancer-related lymphoedema: risk factors and treatment</article-title><source>Br J Nurs</source><year>2009</year><volume>18</volume><fpage>166</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">19223801</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Norman</surname><given-names>SA</given-names></name><name><surname>Localio</surname><given-names>AR</given-names></name><name><surname>Kallan</surname><given-names>MJ</given-names></name><name><surname>Weber</surname><given-names>AL</given-names></name><name><surname>Torpey</surname><given-names>HA</given-names></name><name><surname>Potashnik</surname><given-names>SL</given-names></name><etal></etal><article-title>Risk factors for lymphedema after breast cancer treatment</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2010</year><volume>19</volume><fpage>2734</fpage><lpage>2746</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-09-1245</pub-id><pub-id pub-id-type="pmid">20978176</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Clough-Gorr</surname><given-names>KM</given-names></name><name><surname>Ganz</surname><given-names>PA</given-names></name><name><surname>Silliman</surname><given-names>RA</given-names></name><article-title>Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up</article-title><source>Breast J</source><year>2010</year><volume>16</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1111/j.1524-4741.2009.00878.x</pub-id><pub-id pub-id-type="pmid">19968661</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Meeske</surname><given-names>KA</given-names></name><name><surname>Sullivan-Halley</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>AW</given-names></name><name><surname>McTiernan</surname><given-names>A</given-names></name><name><surname>Baumgartner</surname><given-names>KB</given-names></name><name><surname>Harlan</surname><given-names>LC</given-names></name><etal></etal><article-title>Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</article-title><source>Breast Cancer Res Treat</source><year>2009</year><volume>113</volume><fpage>383</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1007/s10549-008-9940-5</pub-id><pub-id pub-id-type="pmid">18297429</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Goffman</surname><given-names>TE</given-names></name><name><surname>Laronga</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name><name><surname>Elkins</surname><given-names>D</given-names></name><article-title>Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery</article-title><source>Breast J</source><year>2004</year><volume>10</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1111/j.1075-122X.2004.21411.x</pub-id><pub-id pub-id-type="pmid">15327493</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Mak</surname><given-names>SS</given-names></name><name><surname>Yeo</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Tse</surname><given-names>SM</given-names></name><name><surname>Ho</surname><given-names>FP</given-names></name><name><surname>Zee</surname><given-names>B</given-names></name><etal></etal><article-title>Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer</article-title><source>Hong Kong Med J</source><year>2009</year><volume>15</volume><issue>3 Suppl 4</issue><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">19509430</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Hojris</surname><given-names>I</given-names></name><name><surname>Andersen</surname><given-names>J</given-names></name><name><surname>Overgaard</surname><given-names>M</given-names></name><name><surname>Overgaard</surname><given-names>J</given-names></name><article-title>Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone</article-title><source>Acta Oncol</source><year>2000</year><volume>39</volume><fpage>355</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1080/028418600750013131</pub-id><pub-id pub-id-type="pmid">10987233</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Bergmann</surname><given-names>A</given-names></name><name><surname>Mattos</surname><given-names>IE</given-names></name><name><surname>Koiffman</surname><given-names>RJ</given-names></name><name><surname>Ribeiro</surname><given-names>MJP</given-names></name><name><surname>Nogueira</surname><given-names>EA</given-names></name><name><surname>Ribeiro</surname><given-names>EP</given-names></name><etal></etal><article-title>Axillary web syndrome after lumpnode dissection: results for 1004 breast cancer patients</article-title><source>Lymphology</source><year>2007</year><volume>40</volume><issue>Suppl</issue><fpage>198</fpage><lpage>203</lpage></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Leidenius</surname><given-names>M</given-names></name><name><surname>Leppänen</surname><given-names>E</given-names></name><name><surname>Krogerus</surname><given-names>L</given-names></name><name><surname>von Smitten</surname><given-names>K</given-names></name><article-title>Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer</article-title><source>Am J Surg</source><year>2003</year><volume>185</volume><fpage>127</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/S0002-9610(02)01214-X</pub-id><pub-id pub-id-type="pmid">12559441</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Moskovitz</surname><given-names>AH</given-names></name><name><surname>Anderson</surname><given-names>BO</given-names></name><name><surname>Yeung</surname><given-names>RS</given-names></name><name><surname>Byrd</surname><given-names>DR</given-names></name><name><surname>Lawton</surname><given-names>TJ</given-names></name><name><surname>Moe</surname><given-names>RE</given-names></name><article-title>Axillary web syndrome after axillary dissection</article-title><source>Am J Surg</source><year>2001</year><volume>181</volume><fpage>434</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1016/S0002-9610(01)00602-X</pub-id><pub-id pub-id-type="pmid">11448437</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Johansen</surname><given-names>J</given-names></name><name><surname>Overgaard</surname><given-names>J</given-names></name><name><surname>Blichert-Toft</surname><given-names>M</given-names></name><name><surname>Overgaard</surname><given-names>M</given-names></name><article-title>Treatment of morbidity associated with the management of the axilla in breast-conserving therapy</article-title><source>Acta Oncol</source><year>2000</year><volume>39</volume><fpage>349</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1080/028418600750013122</pub-id><pub-id pub-id-type="pmid">10987232</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Mutrie</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>AM</given-names></name><name><surname>Whyte</surname><given-names>F</given-names></name><name><surname>McConnachie</surname><given-names>A</given-names></name><name><surname>Emslie</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><etal></etal><article-title>Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial</article-title><source>BMJ</source><year>2007</year><volume>334</volume><fpage>517</fpage><pub-id pub-id-type="doi">10.1136/bmj.39094.648553.AE</pub-id><pub-id pub-id-type="pmid">17307761</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Beurskens</surname><given-names>CH</given-names></name><name><surname>van Uden</surname><given-names>CJ</given-names></name><name><surname>Strobbe</surname><given-names>LJ</given-names></name><name><surname>Oostendorp</surname><given-names>RA</given-names></name><name><surname>Wobbes</surname><given-names>T</given-names></name><article-title>The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study</article-title><source>BMC Cancer</source><year>2007</year><volume>7</volume><fpage>166</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-7-166</pub-id><pub-id pub-id-type="pmid">17760981</pub-id></mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002A89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:3577444
|texte= Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:23406386" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |